Svai Sanford
2022
In 2022, Svai Sanford earned a total compensation of $2M as Chief Financial Officer at Rani Therapeutics Holdings, a 58% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $249,600 |
|---|---|
| Option Awards | $888,460 |
| Salary | $412,000 |
| Stock Awards | $434,609 |
| Total | $1,984,669 |
Sanford received $888.5K in option awards, accounting for 45% of the total pay in 2022.
Sanford also received $249.6K in non-equity incentive plan, $412K in salary and $434.6K in stock awards.
Rankings
In 2022, Svai Sanford's compensation ranked 1,763rd out of 5,760 executives tracked by ExecPay. In other words, Sanford earned more than 69.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,763 out of 5,760 | 69th |
Division Manufacturing | 925 out of 3,136 | 71st |
Major group Chemicals And Allied Products | 374 out of 1,422 | 74th |
Industry group Drugs | 342 out of 1,323 | 74th |
Industry Pharmaceutical Preparations | 246 out of 969 | 75th |
Source: SEC filing on April 11, 2023.
Sanford's colleagues
We found two more compensation records of executives who worked with Svai Sanford at Rani Therapeutics Holdings in 2022.